Qianjin Pharmaceutical announced that its subsidiary Hunan Qianjin Xiangjiang Pharmaceutical Co., Ltd. recently received the “Drug Registration Certificate” for ferrous succinate tablets and escitalopram oxalate tablets approved and issued by the State Drug Administration. Among them, ferrous succinate tablets were approved to be managed as an over-the-counter drug.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.